MedTrace Logo

Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release Form in the Treatment of Egyptian Osteoarthritic Patients

NCT01226095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 519

Last updated 2013-09-20

Study results available
· View outcomes & findings →

Summary

This is a prospective, multi-center, post-marketing observational study to evaluate the effectiveness and compliance of ibuprofen in a sustained release form in the treatment of Egyptian osteoarthritic patients.

Conditions

Sponsors & Collaborators

  • Clintek

    collaborator UNKNOWN

  • Abbott

    lead INDUSTRY

Principal Investigators

  • Rasha Eldessouky, MBBC · Abbott (Egypt)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01226095 on ClinicalTrials.gov